Luo; Zhi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Luo; Zhi.The latest application filed is for "composition of lanosterol prodrug compound, preparation method therefor and use thereof".

Company Profile

17.10.15

Luo; Zhi - Shanghai CN
Luo; Zhi - Hangzhou CN
Luo; Zhi - Nanjing CN
LUO; Zhi - Pudong New Area Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Composition Of Lanosterol Prodrug Compound, Preparation Method Therefor And Use Thereof App 20220133744 - Liu; Yizhi ; et al.	2022-05-05
Compound For Use In Retinal Diseases App 20220127243 - LI; Peng ; et al.	2022-04-28
Process Route Of Compound Of Formula (iv), Crystal Form And Preparation Method Therefor App 20220024880 - LUO; Zhi ; et al.	2022-01-27
Method, apparatus, and device for processing web application package Grant 11,157,254 - Luo October 26, 2	2021-10-26
Crystal form of lanosterol prodrug compound and application thereof Grant 11,149,055 - Liu , et al. October 19, 2	2021-10-19
Crystal Form Of Lanosterol Prodrug Compound And Application Thereof App 20210246158 - LIU; Yizhi ; et al.	2021-08-12
Ssao Inhibitor App 20210198220 - LUO; Zhi ; et al.	2021-07-01
SSAO inhibitor Grant 11,001,563 - Luo , et al. May 11, 2	2021-05-11
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof Grant 10,981,860 - He , et al. April 20, 2	2021-04-20
Steroid Derivative FXR Agonist App 20210040140 - HE; Haiying ; et al.	2021-02-11
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,912,775 - Wu , et al. February 9, 2	2021-02-09
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,898,486 - Wu , et al. January 26, 2	2021-01-26
Steroid derivative FXR agonist Grant 10,875,888 - He , et al. December 29, 2	2020-12-29
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,874,674 - Wu , et al. December 29, 2	2020-12-29
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261453 - WU; Songliang ; et al.	2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261452 - WU; Songliang ; et al.	2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200253972 - Kind Code	2020-08-13
Lanosterol prodrug compound and preparation method therefor and use thereof Grant 10,738,076 - Liu , et al. A	2020-08-11
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,668,066 - Wu , et al.	2020-06-02
Ssao Inhibitor App 20200115352 - LUO; Zhi ; et al.	2020-04-16
Method, Apparatus, And Device For Processing Web Application Package App 20200110593 - Luo; Zhi	2020-04-09
Steroid Derivative FXR Agonist App 20190382437 - HE; Haiying ; et al.	2019-12-19
Lanosterol Prodrug Compound And Preparation Method Therefor And Use Thereof App 20190256548 - LIU; Yizhi ; et al.	2019-08-22
Caspase Inhibitor And Pharmaceutical Composition, Use And Therapeutic Method Thereof App 20190135733 - He; Haiying ; et al.	2019-05-09
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20180235965 - WU; Songliang ; et al.	2018-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.